Skip to main content
Top
Published in: Internal and Emergency Medicine 3/2018

01-04-2018 | IM - REVIEW

Sarcoidosis: a review for the internist

Authors: Elena Bargagli, Antje Prasse

Published in: Internal and Emergency Medicine | Issue 3/2018

Login to get access

Abstract

Sarcoidosis is a systemic granulomatous lung disease of unknown origin affecting people of any age, mainly young adults. The disease is extremely heterogeneous with an unpredictable clinical course. Different phenotypes have been identified: an acute syndrome can be distinguished from subacute and chronic variants. About 20% of patients are chronically progressive and may develop lung fibrosis. Sarcoidosis usually involves the lungs and thoracic lymph nodes, although the skin, eyes, bones, liver, spleen, heart, upper respiratory tract and nervous system can also be affected. No reliable indicators of clinical outcome are available, and there is no single serological biomarker with demonstrated unequivocal diagnostic and prognostic value. Diagnosis requires histological confirmation although a presumptive diagnosis may be acceptable in special conditions. This review examines the diagnostic approach to sarcoidosis involving a multidisciplinary team of specialists in which the internist has the task of identifying all pulmonary and extrapulmonary localizations of the disease and of managing complications and comorbidities.
Literature
1.
go back to reference Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173PubMed Hunninghake GW, Costabel U, Ando M et al (1999) ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other granulomatous disorders. Sarcoidosis Vasc Diffuse Lung Dis 16:149–173PubMed
2.
go back to reference Moller DR, Chen ES (2002) Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol 27:391–395CrossRefPubMed Moller DR, Chen ES (2002) Genetic basis of remitting sarcoidosis: triumph of the trimolecular complex? Am J Respir Cell Mol Biol 27:391–395CrossRefPubMed
3.
go back to reference Prior C, Knight RA, Herold M (1996) Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 9:47–53CrossRefPubMed Prior C, Knight RA, Herold M (1996) Pulmonary sarcoidosis: patterns of cytokine release in vitro. Eur Respir J 9:47–53CrossRefPubMed
5.
go back to reference Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, Sanyal S, Brillet PY, Brauner M, Kambouchner M, Huynh S, Naccache JM, Borie R, Piquet J, Mekinian A, Virally J, Uzunhan Y, Cadranel J, Crestani B, Fain O, Lhote F, Dhote R, Saidenberg-Kermanac’h N, Rosental PA, Valeyre D, Nunes H (2017) Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J 50(2):1602419. https://doi.org/10.1183/13993003.02419-2016 CrossRefPubMedCentralPubMed Duchemann B, Annesi-Maesano I, Jacobe de Naurois C, Sanyal S, Brillet PY, Brauner M, Kambouchner M, Huynh S, Naccache JM, Borie R, Piquet J, Mekinian A, Virally J, Uzunhan Y, Cadranel J, Crestani B, Fain O, Lhote F, Dhote R, Saidenberg-Kermanac’h N, Rosental PA, Valeyre D, Nunes H (2017) Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris. Eur Respir J 50(2):1602419. https://​doi.​org/​10.​1183/​13993003.​02419-2016 CrossRefPubMedCentralPubMed
6.
go back to reference Chen ES, Song Z, Willett MH, Heine S, Yung RC, Liu MC, Groshong SD, Zhang Y, Tuder RM, Moller DR (2010) Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 181:360–373CrossRefPubMed Chen ES, Song Z, Willett MH, Heine S, Yung RC, Liu MC, Groshong SD, Zhang Y, Tuder RM, Moller DR (2010) Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2. Am J Respir Crit Care Med 181:360–373CrossRefPubMed
7.
go back to reference Lieberman J, Schleissner LA, Nosal A, Sastre A, Mishkin FS (1983) Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. Chest 84:522–528CrossRefPubMed Lieberman J, Schleissner LA, Nosal A, Sastre A, Mishkin FS (1983) Clinical correlations of serum angiotensin-converting enzyme (ACE) in sarcoidosis. A longitudinal study of serum ACE, 67gallium scans, chest roentgenograms, and pulmonary function. Chest 84:522–528CrossRefPubMed
8.
go back to reference Bargagli E, Mazzi A, Rottoli P (2008) Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med 29:445–458CrossRefPubMed Bargagli E, Mazzi A, Rottoli P (2008) Markers of inflammation in sarcoidosis: blood, urine, BAL, sputum, and exhaled gas. Clin Chest Med 29:445–458CrossRefPubMed
9.
go back to reference Landi C, Bargagli E, Carleo A et al (2015) A functional proteomics approach to the comprehension of sarcoidosis. J Proteom 128:375–387CrossRef Landi C, Bargagli E, Carleo A et al (2015) A functional proteomics approach to the comprehension of sarcoidosis. J Proteom 128:375–387CrossRef
10.
go back to reference Bargagli E, Magi B, Olivieri C et al (2011) Analysis of serum amyloid A in sarcoidosis patients. Respir Med 105:775–778CrossRefPubMed Bargagli E, Magi B, Olivieri C et al (2011) Analysis of serum amyloid A in sarcoidosis patients. Respir Med 105:775–778CrossRefPubMed
11.
go back to reference Ivanišević J, Kotur-Stevuljević J, Stefanović A et al (2016) Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients. Eur J Clin Investig 46:418–424CrossRef Ivanišević J, Kotur-Stevuljević J, Stefanović A et al (2016) Association of serum amyloid A and oxidative stress with paraoxonase 1 in sarcoidosis patients. Eur J Clin Investig 46:418–424CrossRef
12.
go back to reference Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Müller-Quernheim J (2008) Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 177(3):330–336CrossRefPubMed Prasse A, Katic C, Germann M, Buchwald A, Zissel G, Müller-Quernheim J (2008) Phenotyping sarcoidosis from a pulmonary perspective. Am J Respir Crit Care Med 177(3):330–336CrossRefPubMed
13.
go back to reference Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. BMJ 4:1165–1172CrossRef Scadding JG (1961) Prognosis of intrathoracic sarcoidosis in England. BMJ 4:1165–1172CrossRef
14.
go back to reference Chaigne B, Guillevin L (2017) Vasculitis for the internist: focus on ANCA-associated vasculitis. Intern Emerg Med 12(5):577–585CrossRefPubMed Chaigne B, Guillevin L (2017) Vasculitis for the internist: focus on ANCA-associated vasculitis. Intern Emerg Med 12(5):577–585CrossRefPubMed
15.
go back to reference Elia F, Aprà F, Crupi V (2017) Understanding and improving decisions in clinical medicine (II): making sense of reasoning in practice. Intern Emerg Med (in press) Elia F, Aprà F, Crupi V (2017) Understanding and improving decisions in clinical medicine (II): making sense of reasoning in practice. Intern Emerg Med (in press)
16.
go back to reference Grunewald J, Eklund A (2009) Lofgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:307–312CrossRefPubMed Grunewald J, Eklund A (2009) Lofgren’s syndrome: human leukocyte antigen strongly influences the disease course. Am J Respir Crit Care Med 179:307–312CrossRefPubMed
17.
18.
go back to reference Descamps V, Bouscarat F (2016) Cutaneous manifestations of sarcoidosis. Ann Dermatol Venereol 143(1):39–50CrossRefPubMed Descamps V, Bouscarat F (2016) Cutaneous manifestations of sarcoidosis. Ann Dermatol Venereol 143(1):39–50CrossRefPubMed
19.
go back to reference Kingah P, Alam M, Chugh K, Kamholz J, Samavati L (2016) Role of pulmonary evaluation in diagnosis of neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 33(3):209–215PubMed Kingah P, Alam M, Chugh K, Kamholz J, Samavati L (2016) Role of pulmonary evaluation in diagnosis of neurosarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 33(3):209–215PubMed
20.
go back to reference McDonnell MJ, Saleem MI, Wall D, Gilmartin JJ, Rutherford RM, O’Regan A (2016) Predictive value of C-reactive protein and clinically relevant baseline variables in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 33(4):331–340PubMed McDonnell MJ, Saleem MI, Wall D, Gilmartin JJ, Rutherford RM, O’Regan A (2016) Predictive value of C-reactive protein and clinically relevant baseline variables in sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 33(4):331–340PubMed
22.
go back to reference Baughman RP, Papanikolaou I (2017) Current concepts regarding calcium metabolism and bone health in sarcoidosis. Curr Opin Pulm Med 23(5):476–481CrossRefPubMed Baughman RP, Papanikolaou I (2017) Current concepts regarding calcium metabolism and bone health in sarcoidosis. Curr Opin Pulm Med 23(5):476–481CrossRefPubMed
23.
go back to reference Minisola S, Cipriani C, Occhiuto M, Pepe J (2017) New anabolic therapies for osteoporosis. Intern Emerg Med 12(7):915–921CrossRefPubMed Minisola S, Cipriani C, Occhiuto M, Pepe J (2017) New anabolic therapies for osteoporosis. Intern Emerg Med 12(7):915–921CrossRefPubMed
24.
go back to reference Kefella H, Luther D, Hainline C (2017) Ophthalmic and neuro-ophthalmic manifestations of sarcoidosis. Curr Opin Pulm Med 28(6):587–594 Kefella H, Luther D, Hainline C (2017) Ophthalmic and neuro-ophthalmic manifestations of sarcoidosis. Curr Opin Pulm Med 28(6):587–594
25.
go back to reference Yang SJ, Salek S, Rosenbaum JT (2017) Ocular sarcoidosis: new diagnostic modalities and treatment. Curr Opin Pulm Med 23(5):458–467CrossRefPubMed Yang SJ, Salek S, Rosenbaum JT (2017) Ocular sarcoidosis: new diagnostic modalities and treatment. Curr Opin Pulm Med 23(5):458–467CrossRefPubMed
26.
go back to reference Velter C, Lipsker D (2016) Cutaneous panniculitis. Rev Med Intern 37(11):743–750CrossRef Velter C, Lipsker D (2016) Cutaneous panniculitis. Rev Med Intern 37(11):743–750CrossRef
27.
go back to reference Kluger N (2017) Cutaneous complications related to tattoos: 31 cases from Finland. Dermatology 233(1):100–109CrossRefPubMed Kluger N (2017) Cutaneous complications related to tattoos: 31 cases from Finland. Dermatology 233(1):100–109CrossRefPubMed
28.
29.
go back to reference Birnbaum AD, French DD, Mirsaeidi M, Wehrli S (2015) Sarcoidosis in the national veteran population: association of ocular inflammation and mortality. Ophthalmology 122(5):934–938CrossRefPubMedCentralPubMed Birnbaum AD, French DD, Mirsaeidi M, Wehrli S (2015) Sarcoidosis in the national veteran population: association of ocular inflammation and mortality. Ophthalmology 122(5):934–938CrossRefPubMedCentralPubMed
30.
go back to reference Bargagli E, Olivieri C, Penza F, Bertelli P, Gonnelli S, Volterrani L, Rottoli P (2011) Rare localizations of bone sarcoidosis: two case reports and review of the literature. Rheumatol Int 31(11):1503–1506CrossRefPubMed Bargagli E, Olivieri C, Penza F, Bertelli P, Gonnelli S, Volterrani L, Rottoli P (2011) Rare localizations of bone sarcoidosis: two case reports and review of the literature. Rheumatol Int 31(11):1503–1506CrossRefPubMed
31.
go back to reference Carter JM, Howe BM, Inwards CY (2017) Conditions simulating primary bone neoplasms. Surg Pathol Clin 10(3):731–748CrossRefPubMed Carter JM, Howe BM, Inwards CY (2017) Conditions simulating primary bone neoplasms. Surg Pathol Clin 10(3):731–748CrossRefPubMed
32.
go back to reference Rottoli P, Bargagli E, Chidichimo C, Nuti D, Cintorino M, Ginanneschi C, Caruso G (2006) Sarcoidosis with upper respiratory tract involvement. Respir Med 100(2):253–257CrossRefPubMed Rottoli P, Bargagli E, Chidichimo C, Nuti D, Cintorino M, Ginanneschi C, Caruso G (2006) Sarcoidosis with upper respiratory tract involvement. Respir Med 100(2):253–257CrossRefPubMed
33.
go back to reference Morgenthau AS, Teirstein AS (2011) Sarcoidosis of the upper and lower airways. Expert Rev Respir Med 5(6):823–833CrossRefPubMed Morgenthau AS, Teirstein AS (2011) Sarcoidosis of the upper and lower airways. Expert Rev Respir Med 5(6):823–833CrossRefPubMed
34.
go back to reference Agrawal A, Sahni S, Iftikhar A, Talwar A (2015) Pulmonary manifestations of renal cell carcinoma. Respir Med 109(12):1505–1508CrossRefPubMed Agrawal A, Sahni S, Iftikhar A, Talwar A (2015) Pulmonary manifestations of renal cell carcinoma. Respir Med 109(12):1505–1508CrossRefPubMed
35.
go back to reference Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, Machac J, Teirstein A (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133:1426–1435CrossRefPubMed Mehta D, Lubitz SA, Frankel Z, Wisnivesky JP, Einstein AJ, Goldman M, Machac J, Teirstein A (2008) Cardiac involvement in patients with sarcoidosis: diagnostic and prognostic value of outpatient testing. Chest 133:1426–1435CrossRefPubMed
36.
go back to reference Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ (2005) Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 128:30–35CrossRefPubMed Smedema JP, Snoep G, van Kroonenburgh MP, van Geuns RJ, Dassen WR, Gorgels AP, Crijns HJ (2005) Cardiac involvement in patients with pulmonary sarcoidosis assessed at two university medical centers in the Netherlands. Chest 128:30–35CrossRefPubMed
37.
go back to reference Culver DA, Ribeiro Neto ML, Moss BP, Willis MA (2017) Neurosarcoidosis. Semin Respir Crit Care Med 38(4):499–513CrossRefPubMed Culver DA, Ribeiro Neto ML, Moss BP, Willis MA (2017) Neurosarcoidosis. Semin Respir Crit Care Med 38(4):499–513CrossRefPubMed
39.
go back to reference Hebel R, Dubaniewicz-Wybieralska M, Dubaniewicz A (2015) Overview of neurosarcoidosis: recent advances. J Neurol 262(2):258–267CrossRefPubMed Hebel R, Dubaniewicz-Wybieralska M, Dubaniewicz A (2015) Overview of neurosarcoidosis: recent advances. J Neurol 262(2):258–267CrossRefPubMed
40.
go back to reference Said G (2013) Sarcoidosis of the peripheral nervous system. Handb Clin Neurol 013(115):485–495CrossRef Said G (2013) Sarcoidosis of the peripheral nervous system. Handb Clin Neurol 013(115):485–495CrossRef
41.
go back to reference Levitt DG, Levitt MD (2017) Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol 10:147–168CrossRefPubMedCentralPubMed Levitt DG, Levitt MD (2017) Protein losing enteropathy: comprehensive review of the mechanistic association with clinical and subclinical disease states. Clin Exp Gastroenterol 10:147–168CrossRefPubMedCentralPubMed
42.
go back to reference Cunha BA, Sivarajah T, Jimada I (2017) Sarcoidosis with fever and a splenic infarct due to CMV or lymphoma? Heart Lung 46(5):394–396CrossRefPubMed Cunha BA, Sivarajah T, Jimada I (2017) Sarcoidosis with fever and a splenic infarct due to CMV or lymphoma? Heart Lung 46(5):394–396CrossRefPubMed
43.
go back to reference Baratto L, Park SY, Hatami N, Davidzon G, Srinivas S, Gambhir SS, Iagaru A (2017) 18F-FDG silicon photomultiplier PET/CT: a pilot study comparing semi-quantitative measurements with standard PET/CT. PLoS One 12(6):e0178936CrossRefPubMedCentralPubMed Baratto L, Park SY, Hatami N, Davidzon G, Srinivas S, Gambhir SS, Iagaru A (2017) 18F-FDG silicon photomultiplier PET/CT: a pilot study comparing semi-quantitative measurements with standard PET/CT. PLoS One 12(6):e0178936CrossRefPubMedCentralPubMed
44.
go back to reference Silva M, Nunes H, Valeyre D, Sverzellati N (2015) Imaging of sarcoidosis. Clin Rev Allergy Immunol 49(1):45–53CrossRefPubMed Silva M, Nunes H, Valeyre D, Sverzellati N (2015) Imaging of sarcoidosis. Clin Rev Allergy Immunol 49(1):45–53CrossRefPubMed
45.
go back to reference Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ (2016) Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag 12:1623–1634CrossRefPubMedCentralPubMed Al-Kofahi K, Korsten P, Ascoli C, Virupannavar S, Mirsaeidi M, Chang I, Qaqish N, Saketkoo LA, Baughman RP, Sweiss NJ (2016) Management of extrapulmonary sarcoidosis: challenges and solutions. Ther Clin Risk Manag 12:1623–1634CrossRefPubMedCentralPubMed
47.
go back to reference Tyan CC, Machuca T, Czarnecka K, Ko HM, da Cunha Santos G, Boerner SL, Pierre A, Cypel M, Waddell T, Darling G, de Perrot M, Keshavjee S, Geddie W, Yasufuku K (2017) Performance of endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of isolated mediastinal and hilar lymphadenopathy. Respiration 94(5):457–464CrossRefPubMed Tyan CC, Machuca T, Czarnecka K, Ko HM, da Cunha Santos G, Boerner SL, Pierre A, Cypel M, Waddell T, Darling G, de Perrot M, Keshavjee S, Geddie W, Yasufuku K (2017) Performance of endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of isolated mediastinal and hilar lymphadenopathy. Respiration 94(5):457–464CrossRefPubMed
48.
go back to reference Ramachandraiah V, Aronow W, Chandy D (2017) Pulmonary sarcoidosis: an update. Postgrad Med 129(1):149–158CrossRefPubMed Ramachandraiah V, Aronow W, Chandy D (2017) Pulmonary sarcoidosis: an update. Postgrad Med 129(1):149–158CrossRefPubMed
49.
go back to reference Presotto L, Busnardo E, Gianolli L, Bettinardi V (2016) An update on technical and methodological aspects for cardiac PET applications. Q J Nucl Med Mol Imaging 60(4):285–307PubMed Presotto L, Busnardo E, Gianolli L, Bettinardi V (2016) An update on technical and methodological aspects for cardiac PET applications. Q J Nucl Med Mol Imaging 60(4):285–307PubMed
50.
go back to reference Mortaz E, Rezayat F, Amani D, Kiani A, Garssen J, Adcock IM, Velayati A (2016) The roles of T helper 1, T helper 17 and regulatory T cells in the pathogenesis of sarcoidosis. Iran J Allergy Asthma Immunol 15(4):334–339PubMed Mortaz E, Rezayat F, Amani D, Kiani A, Garssen J, Adcock IM, Velayati A (2016) The roles of T helper 1, T helper 17 and regulatory T cells in the pathogenesis of sarcoidosis. Iran J Allergy Asthma Immunol 15(4):334–339PubMed
51.
go back to reference Mortaz E, Gudarzi H, Tabarsi P, Adcock IM, Masjedi MR, Jamaati HR, Garssen J, Velayati AA, Redegeld FA (2015) Flow cytometry applications in the study of immunological lung disorders. Iran J Allergy Asthma Immunol 14(1):12–18PubMed Mortaz E, Gudarzi H, Tabarsi P, Adcock IM, Masjedi MR, Jamaati HR, Garssen J, Velayati AA, Redegeld FA (2015) Flow cytometry applications in the study of immunological lung disorders. Iran J Allergy Asthma Immunol 14(1):12–18PubMed
52.
go back to reference Bargagli E, Bennett D, Maggiorelli C et al (2013) Human chitotriosidase: a sensitive biomarker of sarcoidosis. J Clin Immunol 33:264–270CrossRefPubMed Bargagli E, Bennett D, Maggiorelli C et al (2013) Human chitotriosidase: a sensitive biomarker of sarcoidosis. J Clin Immunol 33:264–270CrossRefPubMed
Metadata
Title
Sarcoidosis: a review for the internist
Authors
Elena Bargagli
Antje Prasse
Publication date
01-04-2018
Publisher
Springer International Publishing
Published in
Internal and Emergency Medicine / Issue 3/2018
Print ISSN: 1828-0447
Electronic ISSN: 1970-9366
DOI
https://doi.org/10.1007/s11739-017-1778-6

Other articles of this Issue 3/2018

Internal and Emergency Medicine 3/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.